Abbott today announced positive early results from a study evaluating its investigational Amulet 360 left atrial appendage ...
The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.
Approximately 10.5 million Americans have atrial fibrillation (AFib), a condition that causes an irregular, often too fast, heartbeat. AFib increases the risk of stroke four to five times more than ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rates of patency and device-related thrombus were ...
Medical Device Network on MSN
Abbott reports positive VERITAS study results for AFib
VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.
In the showdown between left atrial appendage (LAA) closure devices, the Amplatzer Amulet outperformed Watchman for peridevice leaks (PDL) in one trial longer term but not in another. At 12 months of ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Boston Scientific Corp. and Abbott Laboratories continue to parry over clinical trials comparing the latter’s Amplatzer Amulet with Boston Scientific’s Watchman in sealing the heart’s left atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results